0000919574-05-001349.txt : 20120613 0000919574-05-001349.hdr.sgml : 20120613 20050329174512 ACCESSION NUMBER: 0000919574-05-001349 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20050330 DATE AS OF CHANGE: 20050329 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: VANTAGEMED CORP CENTRAL INDEX KEY: 0001099531 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] IRS NUMBER: 680383530 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-60909 FILM NUMBER: 05710797 BUSINESS ADDRESS: STREET 1: 3017 KILGORE ROAD STREET 2: SUITE 195 CITY: RANCHO CORDOVE STATE: CA ZIP: 95670-6149 BUSINESS PHONE: 9166384744 MAIL ADDRESS: STREET 1: 3017 KILGORE ROAD STREET 2: SUITE 195 CITY: RANCHO CORDOVA STATE: CA ZIP: 95670-6149 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: S SQUARED TECHNOLOGY CORP /NY CENTRAL INDEX KEY: 0000910030 IRS NUMBER: 133594126 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 515 MADISON AVE STREET 2: SUITE 4200 CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 2124212155 MAIL ADDRESS: STREET 1: 515 MADISON AVE STREET 2: SUITE 4200 CITY: NEW YORK STATE: NY ZIP: 10022 SC 13G 1 d559195_13g.txt SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No.) VantageMed Corporation -------------------------------------------------------------------------------- (Name of Issuer) Common Stock, $.001 par value per share -------------------------------------------------------------------------------- (Title of Class of Securities) 92208W106 -------------------------------------------------------------------------------- (CUSIP Number) March 15, 2005 -------------------------------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [_] Rule 13d-1(c) [_] Rule 13d-1(d) ---------- The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 92208W106 1. NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) S Squared Technology Corp. 13-3594126 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [_] (b) [_] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 2,258,066 6. SHARED VOTING POWER 2,258,066 7. SOLE DISPOSITIVE POWER 2,258,066 8. SHARED DISPOSITIVE POWER 0 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,258,066 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* [_] 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 16.56% 12. TYPE OF REPORTING PERSON* IA ________________________________________________________________________________ CUSIP No. 92208W106 Item 1(a). Name of Issuer: VantageMed Corporation ____________________________________________________________________ Item 1(b). Address of Issuer's Principal Executive Offices: 3017 Kilgore Road, Suite 180 Rancho Cordova, California 95670 ____________________________________________________________________ Item 2(a). Name of Persons Filing: S Squared Technology Corp. ____________________________________________________________________ Item 2(b). Address of Principal Business Office, or if None, Residence: 515 Madison Avenue New York, NY 10022 ____________________________________________________________________ Item 2(c). Citizenship: Delaware ____________________________________________________________________ Item 2(d). Title of Class of Securities: Common Stock, $.001 par value per share ____________________________________________________________________ Item 2(e). CUSIP Number: 92208W106 ____________________________________________________________________ Item 3. If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a: (a) [_] Broker or dealer registered under Section 15 of the Exchange Act. (b) [_] Bank as defined in Section 3(a)(6) of the Exchange Act. (c) [_] Insurance company as defined in Section 3(a)(19) of the Exchange Act. (d) [_] Investment company registered under Section 8 of the Investment Company Act. (e) [X] An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E); (f) [_] An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F); (g) [_] A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G); (h) [_] A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act; (i) [_] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act; (j) [_] Group, in accordance with Rule 13d-1(b)(1)(ii)(J). Item 4. Ownership. Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Amount beneficially owned: 2,258,066 shares ______________________________________________________________________ (b) Percent of class: 16.56% ______________________________________________________________________ (c) Number of shares as to which S Squared Technology Corp. has: (i) Sole power to vote or to direct the vote 2,258,066 shares with sole power to vote or to direct the vote, (ii) Shared power to vote or to direct the vote 2,258,066 shares with shared power to vote or to direct the vote. (iii) Sole power to dispose or to direct the disposition of 2,258,066 shares with sole power to dispose or to direct the disposition of, (iv) Shared power to dispose or to direct the disposition of 0 shares with shared power to dispose or to direct the disposition of. Item 5. Ownership of Five Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities check the following [ ]. N/A _______________________________________________________________________ Item 6. Ownership of More Than Five Percent on Behalf of Another Person. If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than five percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. N/A _______________________________________________________________________ Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. If a parent holding company or Control person has filed this schedule, pursuant to Rule 13d-1(b)(1)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company or control person has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. N/A _______________________________________________________________________ Item 8. Identification and Classification of Members of the Group. If a group has filed this schedule pursuant to s.240.13d-1(b)(1)(ii)(J), so indicate under Item 3(j) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to s.240.13d-1(c) or s.240.13d-1(d), attach an exhibit stating the identity of each member of the group. N/A _______________________________________________________________________ Item 9. Notice of Dissolution of Group. Notice of dissolution of a group may be furnished as an exhibit stating the date of the dissolution and that all further filings with respect to transactions in the security reported on will be filed, if required, by members of the group, in their individual capacity. See Item 5. N/A ______________________________________________________________________ Item 10. Certifications. By signing below we certify that, to the best of our belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having such purpose or effect. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. March 29, 2005 (Date) (Signature) By: /s/ Seymour L. Goldblatt ---------------------------------------- Seymour L. Goldblatt, President (Name/Title) Note. Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties for whom copies are to be sent. Attention. Intentional misstatements or omissions of fact constitute federal criminal violations (see 18 U.S.C. 1001). ** The reporting persons disclaim beneficially ownership of the securities reported herein, except to the extent of their pecuniary interest therein. 00333-0001#559195